MA52704A - Préparation pharmaceutique - Google Patents

Préparation pharmaceutique

Info

Publication number
MA52704A
MA52704A MA052704A MA52704A MA52704A MA 52704 A MA52704 A MA 52704A MA 052704 A MA052704 A MA 052704A MA 52704 A MA52704 A MA 52704A MA 52704 A MA52704 A MA 52704A
Authority
MA
Morocco
Prior art keywords
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Application number
MA052704A
Other languages
English (en)
Inventor
Scott Boyer
Shengzehn Cai
Fredrik Hübinette
Leif Ingemarsson
Original Assignee
Klaria Pharma Holding Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klaria Pharma Holding Ab filed Critical Klaria Pharma Holding Ab
Publication of MA52704A publication Critical patent/MA52704A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA052704A 2018-05-23 2019-05-23 Préparation pharmaceutique MA52704A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1808462.4A GB201808462D0 (en) 2018-05-23 2018-05-23 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
MA52704A true MA52704A (fr) 2021-03-31

Family

ID=62812324

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052704A MA52704A (fr) 2018-05-23 2019-05-23 Préparation pharmaceutique

Country Status (13)

Country Link
US (2) US12005140B2 (fr)
EP (1) EP3796896B1 (fr)
JP (2) JP7419263B2 (fr)
KR (1) KR20210031857A (fr)
CN (1) CN112236133B (fr)
AU (1) AU2019274772B2 (fr)
BR (1) BR112020023741A2 (fr)
CA (1) CA3098112A1 (fr)
GB (1) GB201808462D0 (fr)
IL (1) IL278927B2 (fr)
MA (1) MA52704A (fr)
MX (1) MX2020012336A (fr)
WO (1) WO2019224323A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4631569A3 (fr) 2016-11-15 2025-12-24 Klaria Pharma Holding AB Film d'alginate comprenant un triptan
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
SE544672C2 (en) * 2020-05-07 2022-10-11 Liw Innovation Ab New compositions for oral or nasal use
US12414916B2 (en) 2021-06-10 2025-09-16 Belhaven BioPharma Inc. Dry powder formulations of epinephrine and associated methods
EP4302750A1 (fr) * 2022-07-07 2024-01-10 LTS Lohmann Therapie-Systeme AG Couches minces orales comprenant adrénaline
EP4302751A1 (fr) * 2022-07-07 2024-01-10 LTS Lohmann Therapie-Systeme AG Couches minces oral avec une faible activité d'eau
CN115950999B (zh) * 2022-12-21 2024-08-30 武汉嘉诺康医药技术有限公司 一种同时检测重酒石酸去甲肾上腺素中api游离碱与配对有机酸的hplc检测方法
US12502498B1 (en) 2024-10-21 2025-12-23 Belhaven BioPharma Inc. Compositions, devices, and methods for intranasal delivery of dry powder epinephrine

Family Cites Families (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB933462A (en) * 1958-12-17 1963-08-08 Simone Marie Antoinette Radouc Improvements in or relating to the treatment of meat
US5288498A (en) 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
US5288497A (en) 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US5785989A (en) 1985-05-01 1998-07-28 University Utah Research Foundation Compositions and methods of manufacturing of oral dissolvable medicaments
WO1998001134A1 (fr) 1996-07-10 1998-01-15 Novartis Consumer Health S.A. Combinaisons pharmaceutiques de composes antihistaminiques et de terpenoides destinees a etre administrees par voie orale
ZA976189B (en) 1996-07-12 1999-01-11 Novartis Consumer Health Sa Oral pharmaceutical combinations
US6596298B2 (en) 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
KR100452972B1 (ko) 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US20140271788A1 (en) * 2013-03-15 2014-09-18 Monosol Rx, Llc Sublingual and buccal film compositions
US20040247649A1 (en) 2002-02-11 2004-12-09 Edizone, Lc Medicine-containing orally soluble films
CA2487882A1 (fr) 2002-05-31 2003-12-11 University Of Mississippi Administration par voie transmuqueuse de cannabinoides
DE10226494A1 (de) 2002-06-14 2004-01-08 Lts Lohmann Therapie-Systeme Ag Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
GB0217382D0 (en) 2002-07-26 2002-09-04 Pfizer Ltd Process for making orally consumable dosage forms
US9561182B2 (en) * 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
US20040096569A1 (en) 2002-11-15 2004-05-20 Barkalow David G. Edible film products and methods of making same
US9498454B2 (en) 2003-02-24 2016-11-22 Pharmaceutical Productions Inc. Transmucosal drug delivery system
KR101170844B1 (ko) 2003-02-24 2012-08-02 파마슈티칼 프로덕션스, 인크. 경점막 약물 전달 시스템
US20070059346A1 (en) 2003-07-01 2007-03-15 Todd Maibach Film comprising therapeutic agents
KR20050048056A (ko) 2003-11-18 2005-05-24 (주)케이비피 경구용 소모 필름 조성물
MX2007002053A (es) 2004-08-20 2007-04-26 Dial Corp Metodos y aparatos para un purificador de aire de bajo perfil.
EP2522365B1 (fr) 2004-11-24 2016-10-26 Meda Pharmaceuticals Inc. Compositions comprenant de l'azélastine et leurs procédés d'utilisation
US20060217308A1 (en) 2005-03-10 2006-09-28 Pascale Cossart Compositions for the treatment of tumor pathologies, comprising internalin B (ln1B) of Listeria monocytogene protein or a fragment thereof
PL1863469T3 (pl) * 2005-03-15 2012-05-31 Animal Ethics Pty Ltd Miejscowa kompozycja przeciwbólowa
WO2013059629A1 (fr) 2011-10-21 2013-04-25 Nova Southeastern University Nanoparticules d'épinéphrine, leurs procédés de fabrication et leurs procédés d'utilisation pour le traitement d'états sensibles à l'épinéphrine
WO2007028247A1 (fr) 2005-09-09 2007-03-15 University Of Manitoba Comprimes d'epinephrine a desintegration rapide destines a une administration orale ou sublinguale
GB2423711B (en) 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
SE530184C2 (sv) 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
IL175338A0 (en) 2006-05-01 2006-09-05 Biota Ltd Orally administrable films and preparation thereof
CN101081218A (zh) 2006-06-02 2007-12-05 范敏华 一种口腔速崩膜及其制备方法
TW200816985A (en) 2006-06-05 2008-04-16 Verus Pharmaceuticals Inc Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies
EP1897543A1 (fr) 2006-08-30 2008-03-12 Euro-Celtique S.A. Gaufre de buprénorphine pour la thérapie de substitution
KR100855566B1 (ko) * 2006-09-12 2008-09-03 (주) 아모젠 경구용 소모성 필름
EP2404934A1 (fr) 2006-09-22 2012-01-11 Novo Nordisk A/S Analogues d'insuline résistants à la protéase
US20080269347A1 (en) 2006-09-28 2008-10-30 Azopharma, Inc. Epinephrine formulations
BRPI0720105A2 (pt) * 2006-12-11 2014-10-07 Kempharm Inc Conjugados de aminoácido não padrões de anfetamina e processos para fabricação e uso dos mesmos
CA2676841C (fr) 2007-01-31 2017-09-26 Rutgers, The State University Of New Jersey Liberation controlee d'agents actifs dans la peau
US20100215774A1 (en) 2007-02-09 2010-08-26 Todd Maibach Film comprising nitroglycerin
US20090246273A1 (en) 2008-03-27 2009-10-01 Al-Ghananeem Abeer M Ketorolac Sublingual Spray for the Treatment of Pain
WO2009126132A1 (fr) 2008-03-31 2009-10-15 Mark Rosenberg Formulations et procédés de modulation de la satiété
KR20110056516A (ko) 2008-09-12 2011-05-30 크리티컬 파머수티컬스 리미티드 점막 또는 피부를 통한 치료제의 흡수 개선
US8900634B2 (en) 2008-11-03 2014-12-02 Nal Pharmaceuticals, Ltd. Diethylstilbestrol dosage form and methods of treatment using thereof
US8715715B2 (en) 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
DK2405942T3 (en) * 2009-03-13 2018-02-05 Excellent Tech Products I Sverige Ab PRODUCT FOR ORAL SUBMISSION
CN101574330A (zh) 2009-06-12 2009-11-11 上海现代药物制剂工程研究中心有限公司 苯甲酸利扎曲普坦膜剂
KR101074271B1 (ko) 2009-06-25 2011-10-17 (주)차바이오앤디오스텍 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
KR101646079B1 (ko) 2009-09-25 2016-08-12 닥터 레디스 레보러터리즈 리미티드 트립탄 화합물을 포함하는 제제
ES2712989T3 (es) * 2009-10-30 2019-05-17 Ix Biopharma Ltd Forma de dosificación sólida de disolución rápida
KR101077468B1 (ko) * 2011-03-04 2011-11-07 (주)차바이오앤디오스텍 안정한 경구용 속용 필름 제제
KR101303479B1 (ko) * 2011-07-28 2013-09-06 (주)씨엘팜 가식성 필름형성 조성물 및 약물이 함유된 가식성 필름형 제제
EP2739140A4 (fr) * 2011-07-29 2015-06-03 Shire Llc Promédicaments de l'homoarginine et/ou conjugués d'amphétamines et d'autres stimulants et leurs procédés de fabrication et d'utilisation
WO2013052770A1 (fr) 2011-10-05 2013-04-11 Sanders Jennifer L Procédés et compositions pour traiter une douleur du pied ou de la main
SG11201405958RA (en) * 2012-03-27 2014-10-30 Nicoccino Ab Nicotine formulation
WO2013171146A1 (fr) 2012-05-15 2013-11-21 Lts Lohmann Therapie-Systeme Ag Film oral contenant un résinate d'opiate à libération entérique
US9789071B2 (en) 2012-06-27 2017-10-17 G2B Pharma, Inc. Intranasal formulation of epinephrine for the treatment of anaphylaxis
FR2994844B1 (fr) 2012-08-31 2015-01-02 Assist Publ Hopitaux De Paris Formulation gelifiante a base de ketamine
CN102871984B (zh) 2012-11-05 2015-11-11 天津市聚星康华医药科技有限公司 一种盐酸去氧肾上腺素口腔速溶膜及其制备方法
CN102961365B (zh) * 2012-12-17 2016-01-20 天津市聚星康华医药科技有限公司 硫酸特布他林口腔速溶膜及其制备方法
WO2014137189A1 (fr) * 2013-03-07 2014-09-12 에스케이케미칼주식회사 Film dispersible oral contenant une haute teneur en médicament, et son procédé de fabrication
WO2014160404A1 (fr) 2013-03-13 2014-10-02 The Regents Of The University Of California Dispositifs pour médicaments à usage oral et formulations médicamenteuses améliorés
CN105283170B (zh) * 2013-06-17 2019-10-18 弗里蒙特集团有限公司 包含肾上腺素和柠檬酸的可注射的药物组合物
DE202013105715U1 (de) 2013-08-22 2014-02-19 Sipnose Ltd. Vorrichtung zur Abgabe einer vorbestimmten Menge einer Substanz an eine natürliche Öffnung des Körpers
WO2015034678A2 (fr) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticostéroïde contenant des compositions de comprimés se désintégrant par voie orale pour œsophagite à éonisophiles
US20160303040A1 (en) * 2013-11-19 2016-10-20 Rigshospitalet Injectable pharmaceutical compositions comprising prostacyclin
EP3082816B1 (fr) 2013-12-20 2019-03-20 Indivior UK Limited Compositions de naloxone intranasales et leurs procédés de préparation et d'utilisation
CA2945818C (fr) 2014-04-15 2022-05-03 Vizuri Health Sciences Llc Compositions topiques renfermant un capsaicinoide servant a soulager la douleur, fabrication et utilisation
US9044390B1 (en) 2014-04-17 2015-06-02 Gary J. Speier Pharmaceutical composition and method of manufacturing
WO2015195708A1 (fr) 2014-06-16 2015-12-23 Loewi LLC Procédés d'anesthésie de tissu nerveux dans la voie du nerf trijumeau et utilisations médicales de ceux-ci
US10307397B2 (en) 2014-07-28 2019-06-04 Concept Matrix Solutions Oral dissolvable film that includes plant extract
SMT201900031T1 (it) 2014-07-31 2019-02-28 Pharmathen Sa Composizione di film orosolubile comprendente enalapril per il trattamento di ipertensione in una popolazione pediatrica
US10383950B2 (en) 2014-08-14 2019-08-20 Helmholtz-Zentrum Fur Infektionsforschung Gmbh (De/De) Methods and compositions of carrier systems for the purpose of intracellular drug targeting
CN105878171A (zh) 2014-12-22 2016-08-24 南京海恒医药科技有限公司 一种依达拉奉新制剂及其制备方法
WO2016161537A1 (fr) 2015-04-08 2016-10-13 Maxinase Life Sciences Limited Compositions bio-adhésives pour administration intranasale de granistron
US10064816B2 (en) 2015-06-11 2018-09-04 ReJoy Treatment of sexual dysfunction
CN107847469A (zh) 2015-06-27 2018-03-27 美国神农制药责任有限公司 氯胺酮透皮递送系统
WO2017020125A1 (fr) 2015-07-31 2017-02-09 Delivra Inc. Préparations transdermiques pour administration de capsaïcinoïdes
US20170079907A1 (en) 2015-09-18 2017-03-23 Insys Development Company, Inc. Sublingual Epinephrine Spray
US10039710B2 (en) 2015-09-18 2018-08-07 Insys Development Company, Inc. Epinephrine spray formulations
US9833461B2 (en) 2015-10-23 2017-12-05 Ctt Pharma Inc. Therapeutic compositions comprising cannabidiol and corticosteroids
US20170196896A1 (en) 2016-01-07 2017-07-13 Viramal Limited Gel compositions for transdermal delivery to maximize drug concentrations in the stratum corneum and serum and methods of use thereof
CN108883308A (zh) 2016-01-26 2018-11-23 利维申制药有限公司 α-肾上腺素能药剂的组合物和用途
JPWO2017135195A1 (ja) * 2016-02-03 2018-11-22 社会医療法人蘇西厚生会 まつなみリサーチパーク アレルギー症状の予防又は治療剤
CA3020798A1 (fr) 2016-04-12 2017-10-19 Scott SCHANEVILLE Films a ingerer contenant des substances provenant du chanvre ou du cannabis
US20170290776A1 (en) 2016-05-05 2017-10-12 Monosol Rx, Llc Pharmaceutical compositions with enhanced permeation
US12427121B2 (en) * 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
JP7653218B2 (ja) 2016-05-05 2025-03-28 アクエスティブ セラピューティクス インコーポレイテッド 送達増強エピネフリン組成物
US20180125977A1 (en) 2016-05-05 2018-05-10 Monosol Rx, Llc Enhanced delivery epinephrine compositions
US20190350881A1 (en) * 2016-06-17 2019-11-21 Ys Pharmtech Stabilization of epinephrine formulations
EP4631569A3 (fr) 2016-11-15 2025-12-24 Klaria Pharma Holding AB Film d'alginate comprenant un triptan
CN107080745A (zh) 2017-04-14 2017-08-22 宁夏医科大学 一种载叶黄素白蛋白纳米粒的口腔速溶膜及其制备方法
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
GB201807942D0 (en) 2018-05-16 2018-06-27 Klaria Pharma Holding Ab Pharmaceutical formulation
GB201911715D0 (en) 2019-08-15 2019-10-02 Klaria Pharma Holding Ab Film formulation comprising carriers
GB201912505D0 (en) 2019-08-30 2019-10-16 Klaria Pharma Holding Ab Pharmaceutical formulation
IL292534A (en) 2019-11-04 2022-06-01 Maabarot Products Ltd Orally administrable films comprising poorly water soluble active ingredients and preparation thereof

Also Published As

Publication number Publication date
JP7419263B2 (ja) 2024-01-22
GB201808462D0 (en) 2018-07-11
JP2021526519A (ja) 2021-10-07
EP3796896A1 (fr) 2021-03-31
US12005140B2 (en) 2024-06-11
IL278927B1 (en) 2024-09-01
CN112236133B (zh) 2025-02-25
IL278927A (en) 2021-01-31
US20250099374A1 (en) 2025-03-27
KR20210031857A (ko) 2021-03-23
CA3098112A1 (fr) 2019-11-28
AU2019274772B2 (en) 2024-11-21
CN112236133A (zh) 2021-01-15
WO2019224323A1 (fr) 2019-11-28
AU2019274772A1 (en) 2020-11-19
JP2024050598A (ja) 2024-04-10
US20210369601A1 (en) 2021-12-02
MX2020012336A (es) 2021-01-29
IL278927B2 (en) 2025-01-01
BR112020023741A2 (pt) 2021-02-09
EP3796896B1 (fr) 2025-12-31

Similar Documents

Publication Publication Date Title
MA52704A (fr) Préparation pharmaceutique
EP3493799A4 (fr) Composition pharmaceutique decannabis
MA45562A (fr) Préparation pharmaceutique liquide stable
EP3493798A4 (fr) Composition pharmaceutique decannabis
EP3454899C0 (fr) Composition pharmaceutique
MA47816A (fr) Composition pharmaceutique comprenant du sélexipag
DK3935068T3 (da) Abirateron-prodrugs
MA43705A (fr) Formulation pharmaceutique
EP3452075A4 (fr) Composition pharmaceutique ophtalmique
MA42964A (fr) Préparation pharmaceutique anti-vieillissement
IL285674A (en) Pharmaceutical formulations
HUE059584T2 (hu) Gyógyszerészeti készítmény vérszegénység kezelésére
EP3603642A4 (fr) Préparation pharmaceutique
IL283900A (en) Pharmaceutical combinations
MA47516A (fr) Composition pharmaceutique
EP3402470A4 (fr) Composition pharmaceutique stable
MA53294A (fr) Préparation de bactériophages
EP3383371A4 (fr) Formulation pharmaceutique
EP4015001A4 (fr) Composition pharmaceutique orale
EP3582759A4 (fr) Composition pharmaceutique bioéquivalente de bromhydrate de vortioxétine
EP3646866A4 (fr) Préparation pharmaceutique
EP3894418A4 (fr) Préparation de triiodosilanes
EP3646867A4 (fr) Composition pharmaceutique
EP3646863A4 (fr) Composition pharmaceutique
DK3773595T3 (da) Farmaceutiske anticancer-sammensætninger til kombineret terapi